Global Biopharmaceutical Contract Manufacturing Market Insights, Forecast to 2028

Table Of Contents

1 Report Business Overview

1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Growth Factors 1.2.3 Interferons 1.2.4 Monoclonal Antibodies 1.2.5 Recombinant Hormones 1.2.6 Vaccines 1.2.7 Insulin 1.2.8 Others 1.3 Market by Application 1.3.1 Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Autoimmune Diseases 1.3.3 Oncology 1.3.4 Metabolic Diseases 1.3.5 Ophthalmology 1.3.6 Cardiovascular Diseases 1.3.7 Infectious Diseases 1.3.8 Neurology 1.3.9 Respiratory Disorders 1.3.10 Others 1.4 Study Objectives 1.5 Years Considered2 Global Growth Trends 2.1 Global Biopharmaceutical Contract Manufacturing Market Perspective (2017-2028) 2.2 Biopharmaceutical Contract Manufacturing Growth Trends by Region 2.2.1 Biopharmaceutical Contract Manufacturing Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Biopharmaceutical Contract Manufacturing Historic Market Size by Region (2017-2022) 2.2.3 Biopharmaceutical Contract Manufacturing Forecasted Market Size by Region (2023-2028) 2.3 Biopharmaceutical Contract Manufacturing Market Dynamics 2.3.1 Biopharmaceutical Contract Manufacturing Industry Trends 2.3.2 Biopharmaceutical Contract Manufacturing Market Drivers 2.3.3 Biopharmaceutical Contract Manufacturing Market Challenges 2.3.4 Biopharmaceutical Contract Manufacturing Market Restraints3 Competition Landscape by Key Players 3.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue 3.1.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue (2017-2022) 3.1.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Players (2017-2022) 3.2 Global Biopharmaceutical Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing Revenue 3.4 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio 3.4.1 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing Revenue in 2021 3.5 Biopharmaceutical Contract Manufacturing Key Players Head office and Area Served 3.6 Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service 3.7 Date of Enter into Biopharmaceutical Contract Manufacturing Market 3.8 Mergers & Acquisitions, Expansion Plans4 Biopharmaceutical Contract Manufacturing Breakdown Data by Type 4.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Type (2017-2022) 4.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2023-2028)5 Biopharmaceutical Contract Manufacturing Breakdown Data by Application 5.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Application (2017-2022) 5.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2023-2028)6 North America 6.1 North America Biopharmaceutical Contract Manufacturing Market Size (2017-2028) 6.2 North America Biopharmaceutical Contract Manufacturing Market Size by Type 6.2.1 North America Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022) 6.2.2 North America Biopharmaceutical Contract Manufacturing Market Size by Type (2023-2028) 6.2.3 North America Biopharmaceutical Contract Manufacturing Market Share by Type (2017-2028) 6.3 North America Biopharmaceutical Contract Manufacturing Market Size by Application 6.3.1 North America Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022) 6.3.2 North America Biopharmaceutical Contract Manufacturing Market Size by Application (2023-2028) 6.3.3 North America Biopharmaceutical Contract Manufacturing Market Share by Application (2017-2028) 6.4 North America Biopharmaceutical Contract Manufacturing Market Size by Country 6.4.1 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) 6.4.2 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada7 Europe 7.1 Europe Biopharmaceutical Contract Manufacturing Market Size (2017-2028) 7.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Type 7.2.1 Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022) 7.2.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2023-2028) 7.2.3 Europe Biopharmaceutical Contract Manufacturing Market Share by Type (2017-2028) 7.3 Europe Biopharmaceutical Contract Manufacturing Market Size by Application 7.3.1 Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022) 7.3.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2023-2028) 7.3.3 Europe Biopharmaceutical Contract Manufacturing Market Share by Application (2017-2028) 7.4 Europe Biopharmaceutical Contract Manufacturing Market Size by Country 7.4.1 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) 7.4.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries8 Asia-Pacific 8.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size (2017-2028) 8.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Type 8.2.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Share by Type (2017-2028) 8.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Application 8.3.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Share by Application (2017-2028) 8.4 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region 8.4.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Biopharmaceutical Contract Manufacturing Market Size (2017-2028) 9.2 Latin America Biopharmaceutical Contract Manufacturing Market Size by Type 9.2.1 Latin America Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022) 9.2.2 Latin America Biopharmaceutical Contract Manufacturing Market Size by Type (2023-2028) 9.2.3 Latin America Biopharmaceutical Contract Manufacturing Market Share by Type (2017-2028) 9.3 Latin America Biopharmaceutical Contract Manufacturing Market Size by Application 9.3.1 Latin America Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022) 9.3.2 Latin America Biopharmaceutical Contract Manufacturing Market Size by Application (2023-2028) 9.3.3 Latin America Biopharmaceutical Contract Manufacturing Market Share by Application (2017-2028) 9.4 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country 9.4.1 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) 9.4.2 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil10 Middle East & Africa 10.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size (2017-2028) 10.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Type 10.2.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Share by Type (2017-2028) 10.3 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Application 10.3.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Share by Application (2017-2028) 10.4 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country 10.4.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE11 Key Players Profiles 11.1 Lonza Group 11.1.1 Lonza Group Company Details 11.1.2 Lonza Group Business Overview 11.1.3 Lonza Group Biopharmaceutical Contract Manufacturing Introduction 11.1.4 Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) 11.1.5 Lonza Group Recent Developments 11.2 Baxter Biopharma Solutions 11.2.1 Baxter Biopharma Solutions Company Details 11.2.2 Baxter Biopharma Solutions Business Overview 11.2.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Introduction 11.2.4 Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) 11.2.5 Baxter Biopharma Solutions Recent Developments 11.3 Samsung 11.3.1 Samsung Company Details 11.3.2 Samsung Business Overview 11.3.3 Samsung Biopharmaceutical Contract Manufacturing Introduction 11.3.4 Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) 11.3.5 Samsung Recent Developments 11.4 Fujifilm Diosynth Biotechnologies 11.4.1 Fujifilm Diosynth Biotechnologies Company Details 11.4.2 Fujifilm Diosynth Biotechnologies Business Overview 11.4.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Introduction 11.4.4 Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) 11.4.5 Fujifilm Diosynth Biotechnologies Recent Developments 11.5 Boehringer Ingelheim 11.5.1 Boehringer Ingelheim Company Details 11.5.2 Boehringer Ingelheim Business Overview 11.5.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Introduction 11.5.4 Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) 11.5.5 Boehringer Ingelheim Recent Developments 11.6 Patheon 11.6.1 Patheon Company Details 11.6.2 Patheon Business Overview 11.6.3 Patheon Biopharmaceutical Contract Manufacturing Introduction 11.6.4 Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) 11.6.5 Patheon Recent Developments 11.7 Rentschler Biotechnologie 11.7.1 Rentschler Biotechnologie Company Details 11.7.2 Rentschler Biotechnologie Business Overview 11.7.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Introduction 11.7.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) 11.7.5 Rentschler Biotechnologie Recent Developments 11.8 Biomeva 11.8.1 Biomeva Company Details 11.8.2 Biomeva Business Overview 11.8.3 Biomeva Biopharmaceutical Contract Manufacturing Introduction 11.8.4 Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) 11.8.5 Biomeva Recent Developments 11.9 Probiogen 11.9.1 Probiogen Company Details 11.9.2 Probiogen Business Overview 11.9.3 Probiogen Biopharmaceutical Contract Manufacturing Introduction 11.9.4 Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) 11.9.5 Probiogen Recent Developments 11.10 Cytovance Biologics 11.10.1 Cytovance Biologics Company Details 11.10.2 Cytovance Biologics Business Overview 11.10.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Introduction 11.10.4 Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) 11.10.5 Cytovance Biologics Recent Developments 11.11 KBI Biopharma 11.11.1 KBI Biopharma Company Details 11.11.2 KBI Biopharma Business Overview 11.11.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Introduction 11.11.4 KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) 11.11.5 KBI Biopharma Recent Developments 11.12 WuXi Biologics 11.12.1 WuXi Biologics Company Details 11.12.2 WuXi Biologics Business Overview 11.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Introduction 11.12.4 WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) 11.12.5 WuXi Biologics Recent Developments 11.13 Abzena 11.13.1 Abzena Company Details 11.13.2 Abzena Business Overview 11.13.3 Abzena Biopharmaceutical Contract Manufacturing Introduction 11.13.4 Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) 11.13.5 Abzena Recent Developments12 Analyst's Viewpoints/Conclusions13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer